Harvard Bioscience Inc (NASDAQ:HBIO)
| 4.93 Delayed Data As of Dec 07 |  +0.16 / +3.35%Today’s Change | 1.98 Today|||52-Week Range 6.29 | +77.98% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 108.7M | 104.5M | 101.9M | 120.8M | |
| Cost of Goods Sold | 58.2M | 54.6M | 52.9M | 55.1M | ||
| Depreciation And Amortization | 4.6M | 4.3M | 3.8M | 7.8M | ||
| Operating Expenses | Gross Income | 45.9M | 45.7M | 45.2M | 57.8M | |
| General Expenses | 46.8M | 46.7M | 45.3M | 56.8M | ||
| Other Operating Expenses | -24.0K | 143.0K | 60.0K | 0.00 | ||
| Research And Development | 6.4M | 5.4M | 5.6M | 11.0M | ||
| Total Operating Expenses | 109.6M | 105.7M | 102.0M | 119.8M | ||
| Non-Operating Expenses | Operating Income | -925.0K | -1.1M | -101.0K | 984.0K | |
| Extraordinary Charge | -2.0M | -772.0K | -500.0K | -3.4M | ||
| Interest Expense On Debt | 761.0K | 603.0K | 774.0K | 5.5M | ||
| Other Expenses | 58.0K | -571.0K | -713.0K | -56.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -3.6M | -3.1M | -2.1M | -8.0M | |
| Income Taxes | -15.4M | -1.2M | -1.2M | -3.7M | ||
| Discontinued Operations | 0.00 | 0.00 | 0.00 | 126.0K | ||
| Extraordinary Items | 0.00 | 0.00 | 0.00 | 1.3M | ||
| Net Income | -19.0M | -4.3M | -865.0K | -4.2M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 33.6M | 34.2M | 34.8M | 36.5M | |
| Shares To Calculate EPS Diluted | 33.6M | 34.2M | 34.8M | 36.5M | ||
| Earnings Per Share | EPS | -$0.57 | -$0.13 | -$0.02 | -$0.08 | |
| EPS Diluted | -$0.57 | -$0.13 | -$0.02 | -$0.11 | ||
